BriaCell Therapeutics Corp.
Symbol:
TSX: BCT
NQ: BCTX
Market Cap:
Private
Sector:
Biotech
Summary:
- BriaCell’s immunotherapy approach to treating Breast Cancer harnesses the body’s own cancer-fighting cells
- Phase II clinical trial, partnered with Incyte, has shown survival benefits in advanced metastatic breast cancer patients
- FDA fast track award